Floatz logo

SULFAMIDE, N-(((2S)-6-CHLORO-2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHYL)-

Depressive Disorder

Janssen Research & Development, LLCSmall moleculePhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
73/ 100

Competitive context

91 Active assets in the Depressive Disorder cohort.

Asset / SponsorPhaseRating
Opc-34712
Dr. Albert Kar-Kin Chung
Phase 4A
Saredutant
Sanofi
Phase 3BBB
S-Ketamine
Chinese PLA General Hospital
Phase 4BBB
Cipralex
Poznan University of Medical Sciences
Phase 4BBB
FLUOXETINE
University of Oxford
Phase 4BBB

View all 50 →

Same molecule, other indications

SULFAMIDE, N-(((2S)-6-CHLORO-2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHYL)- is also rated in:

photosensitive epilepsyDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →